This month, the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for breast cancer were updated to recommend ribociclib (Kisqali) as a Category 1 preferred CDK4/6 inhibitor (CDK4/6i) ...

Nothing OS 3.0 Open Beta arrives for the Nothing Phone 2 tomorrow. The in-development software release is built on Android 15. Availability for the Phone 1, Phone 2a Plus, and CMF Phone 1 will get ...

OnePlus has revealed that Oxygen OS 15 will be announced on October 24, 2024, at 6 am ET. The teaser mentions smooth animation effects, refreshed design, improved multi-tasking, and AI updates as ...

By The Learning Network A new collection of graphs, maps and charts organized by topic and type from our “What’s Going On in This Graph?” feature. By The Learning Network Want to learn ...

In the textbooks, each of those relationships is drawn as a curve in a graph. First is the IS (“investment–saving”) curve. This says that if everything else stays the same, the Reserve Bank ...

The question is, after such strong roots have been set for Android and iOS, can another mobile OS thrive? HarmonyOS Next Is Huawei Completely Severing Its Dependence On The US-Based Google Image ...

Here’s where things get interesting. A new rumor now suggests that Huawei may consider a dual-OS strategy for its upcoming phones. According to tech leaker RuiPlaysDigital, the Mate 70 series ...

The new edition of Harmony OS, dubbed Harmony OS Next, will also debut alongside the Nova 13 series. The company will likely confirm the release schedule of the new software for various products ...

Forces both locally and in international markets have clearly been pushing the Phillips curve down, producing lower inflation. Photo / 123RF Economists working on macroeconomic policy – things ...

Nelson Aguilar is an LA-based tech how-to writer and graduate of UCLA. With more than a decade of experience, he covers Apple and Google and writes on iPhone and Android features, privacy and ...

Their research suggested that neoadjuvant therapy with a combination of ribociclib and letrozole could be an alternative to multi-drug neoadjuvant chemotherapy. The trial involved high risk ...